Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Myfocept 250mg Capsule
Manufacturer/Marketed By : APRAZER HEALTHCARE PVT LTD
$3.55 $2.13
Myfocept 250mg Capsule is an immunosuppressant with an active ingredient called Mycophenolate mofetil. It belongs to the inosine monophosphate dehydrogenase (IMPDH) inhibitor category. This medicine is used to prevent organ...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
MYCOPHENOLATE MOFETIL
Active Pharmaceutical Ingredient
Myfocept 250mg Capsule
3,55 $US
2,13 $US
Myfocept 250mg Capsule is an immunosuppressant with an active ingredient called Mycophenolate mofetil. It belongs to the inosine monophosphate dehydrogenase (IMPDH) inhibitor category. This medicine is used to prevent organ rejection in individuals who have previously received an organ transplant (such as kidney, heart, or liver transplantation). It is prescribed as part of a combination therapy that includes other immunosuppressive drugs. This medicine is contraindicated during pregnancy due to the risk of birth defects and miscarriage. It should not be advised in pregnant women unless there are no relevant alternatives and the potential benefits outweigh the risks. Women of birthing age are highly advised to use effective contraception while taking this tablet to prevent pregnancy. Live vaccines should not be administered while a person is taking a Myfocept 250mg Capsule due to reduced vaccine effectiveness and the risk of infection. Individuals taking this drug should not donate blood during treatment and at least six weeks after stopping treatment. It ensures that the medication has been adequately cleared from the body before donating blood. It is generally advised not to take this medicine if you are allergic to the drug or any other ingredients. Inform your doctor of liver or heart disease before initiating the treatment. As this drug reduces the body's immune defences, it can increase the chance of skin cancer. Individuals must take precautions to limit their exposure to sunlight and ultraviolet (UV) light. Seek your doctor immediately if you develop any bruising under the skin, fever, unexplained tiredness, dizziness, yellowing of the skin or eyes, vision impairment, reduced urine output, or seizures after taking this medicine. Myfocept 250mg Capsule is an immunosuppressive medication. It may affect the infant's developing immune system and should be avoided in breastfeeding. In some cases, alternative medications with a more favourable safety profile during breastfeeding may be considered.
Active Pharmaceutical Ingredient
Uses
• Prevent organ transplant rejections
Benefits
Myfocept 250mg Capsule works by inhibiting the enzyme inosine monophosphate dehydrogenase (IMPDH) and reducing the production of guanosine nucleotides. MMF specifically affects the proliferation of activated T and B lymphocytes. These lymphocytes are key players in the immune response that can lead to the rejection of a transplanted organ.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Higher risk of developing lymphoma and other cancers
• Nausea, abdominal pain
• Diarrhea
• Constipation
• Loss of appetite
• Shortness of breath
• Weight loss
• Increased heartbeat
• Headache
• Blood pressure problem
• Anaemia
Common Side Effects
• Infections, fever, or sore throat
• Unusual bleeding or bruising
• Low blood cell count
• Severe allergic reactions
How To Use
It is an orally available prescription drug. Your physician will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Always take Myfocept 250mg Capsule as prescribed by your doctor. Do not open, crush, break, or chew the medicine.
Safety Advice
• Breast Feeding: Myfocept 250mg Capsule is not recommended for breastfeeding mothers because small amounts of the drug can pass into the mother's milk and affect the nursing baby.
• Alcohol: It is unsafe to consume alcohol when taking Myfocept 250mg Capsule because it may cause excessive drowsiness or liver problems.
• Liver: It is generally considered safe for individuals with liver disease, including those with liver transplants. The dosage and use of Myfocept 250mg Capsule may need to be adjusted based on the severity of liver impairment.
• Lungs: Myfocept 250mg Capsule should be cautiously administered in patients with lung diseases. Dose adjustments are necessary. Inform your physician if you have lung problems before initiating the therapy.
• Driving: Driving vehicles or operating machinery while taking Myfocept 250mg Capsule is unsafe because it may cause drowsiness and vision problems.
• Pregnancy: Myfocept 250mg Capsule is known to have harmful effects on the developing fetus and is generally not prescribed for use during pregnancy unless the benefits outweigh the risks.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.